cv of jn sharma

Curriculum Vitae of Jagdish N. Sharma

CURRICULUM VITAE

1

JAGDISH N. SHARMA Ph.D. (UK), D.Sc. (UK), F.C.P. (USA), F. I. Biol., FSB (UK), Professor Department of Pharmacology and Therapeutics, Faculty of Pharmacy Health Sciences Center

Kuwait University P.O.Box 24923, Safat 13110, Kuwait


CONTENTS PAGE NO

I. PERSONAL PARTICULARS AND PRESENT APPOINTMENT 3

II. ACADEMIC QUALIFICATIONS AND FELLOWSHIPS 3

III. PRESENT AND PREVIOUS ACADEMIC AND RESEARCH POSITIONS 4

IV. ADMINISTRATIVE DUTIES AS A CHAIRMAN 6

V. EDITORIAL AND ADVISORY BOARD MEMBER OF INTERNATIONAL 6

JOURNALS

VI. ADVISORY BOARD MEMBER OF INTERNATIONAL CONFERENCES 7

VII. EDITORIAL BOARD MEMBER OF NATIONAL JOURNALS 7

VIII. AWARDS AND EXTERNAL ASSESSOR FOR PROMOTION TO FULL PROFESSOR 8

AND TO THE RANK OF ASSOCIATE PROFESSOR 9

IX. MEMBERSHIP OF PROFESSIONAL LEARNED SOCIETY 9

X. POSITIONS IN INTERNATIONAL CONFERENCES 9

XI. SPECIAL INVITED GUEST LECTURES AND PLENARY LECTURE 9

XII. RESEARCH DEVELOPMENT AREAS AND RESEARCH GRANTS

Supervision of Research projects for Higher Degrees 11

Short –term University research grants 11

Long-term Research and development Grants 12

Personal Research Development 12

International Research Collaboration 12

XIII. EXAMINER OF PH.D. THESES 13

XIV. TEACHING 14

Undergraduate (M.D., M.B. Ch.B., B. Pharm. (Hons)

Nursing and Medical Technologist

Postgraduate (M.Med., M. Pharm., M.Sc., Ph.D.)

XV. BOOK AND FULL PUBLICATIONS 16

XVI. ABSTRACTS AND PRESENTATIONS IN INTERNATIONAL AND 27

NATIONAL CONFERENCES

XVII. ADVISOR AND EVALUATOR OF INTERNATIONAL RESEARCH GRANTS 34

XVIII. REFERENCES 36

2


I. PERSONAL PARTICULARS

Surname SHARMA

First & Middle Names JAGDISH NARAIN

Nationality Canadian

Date of Birth 15 July, 1947

Marital Status Married and having 4 children

Permanent Address 79 Stirling Crescent St. John’s

NL, A1A 4J9, Canada

T el: +1-709-754-2464

Institutional Corresponding Professor J.N. Sharma

Address Department of Pharmacology and

Therapeutics

Faculty of Pharmacy, Health Sciences Center

Kuwait University

P.O.Box 24923, Safat 13110, Kuwait

Email: [email protected]

II. ACADEMIC QUALIFICATIONS AND FELLOWSHIPS

Degree Year University and Institution Specialization

B.V.Sc. & A.H. 1970 Jawaharlal Nehru Agricultural Veterinary Medicine

(D.V.M.) University, Jabalpur, M.P. India and Surgery

M.Sc. 1973 All-India Institute of Medical Medical

Sciences, New Delhi, India Pharmacology

Ph.D. 1976 University of Strathclyde, Pharmacology

Glasgow, Scotland, UK

D.Sc. 2011 Calamus International University, Health Sciences

3

mailto:[email protected]


London , UK.

F.C.P. 1995 Fellow of the American College of Clinical

Pharmacology, New York, USA

F.I.Biol. 1997 Fellow of the Institute of Biology,

London, UK

C. Biol., F.S.B. 2009 Fellow of the Society of Biology, London UK

III. PRESENT AND PREVIOUS ACADEMIC AND RESEARCH POSITIONS

Full Professor Department of Applied Therapeutics

Faculty of Pharmacy, Kuwait University, Kuwait

October 1999 – to date

Founding Chairman Department of Pharmacology and Applied Therapeutics

Faculty of Pharmacy, Kuwait University, Kuwait

January 2000 – May 2005.

Full Professor Department of Pharmacology

School of Medical Sciences and Pharmaceutical Sciences

Universiti Sains Malaysia

Penang, Malaysia

July 1991 – October 1999

Associate Professor Department of Pharmacology

School of Medical Sciences

Universiti Sains Malaysia

Penang, Malaysia

January 1987 – June 1991

Guest Professor Faculty of Pharmacy, Chiang Mai University

Chiang Mai, Thailand, June, 2006.

4


Visiting Professor Department of Surgery, Faculty of Medicine

Queen’s University

Kingston, Ontario, Canada

December 1991

Guest Speaker Faculty of Medicine Memorial University

St. John’s, Newfoundland, Canada

December 1991.

Senior Research Fellow/ Faculty of Medicine and Nursing

Visiting Professor Memorial University of Newfoundland

St. John’s, Newfoundland, Canada.

November 1981 – June 1983 – November 1986

Visiting Professor Department of Pharmacology

Faculty of Medicine, University of Al-Fateh

Tripoli, Libya

March 1981

Consultant / Senior Division of Pharmacology and Toxicology

Lecturer Medical School, University of Malta, Malta

September 1980 – August 1981

Lecturer Department of Pharmacology

Faculty of Medicine, University of Al-Fateh

Tripoli, Libya

March 1978 – August 1980

Visiting Research Fellow Department of Pharmacology and Physiology

University of Strathclyde

Glasgow, Scotland, U.K.

September 1978

Postdoctoral Fellow Department of Pharmacology and Physiology

5


University of Strathclyde, Glasgow, U.K.

October 1976 – March 1978

Demonstrator Department of pharmacology and Physiology

University of Strathclyde

Glasgow, Scotland, U.K.

October 1975 – September 1976

Research Assistant / Department of Pharmacology

Teaching Fellow All- India Institute of Medical Sciences

New Delhi, India

January 1971 – September 1973

IV. ADMINISTRATIVE DUTIES AS A CHAIRMAN

1. Development of the curriculum for Applied Therapeutics and Elective courses.

2. Chairman of the Department of Applied Therapeutics of academic and technical staff appointment committee.

3. Member of the Faculty of Pharmacy Council.

4. Member of the Dean’s Executive Committee for contributions to develop the faculty.

5. Member of the Faculty of Pharmacy selection committee for various departments.

6. Member of the Faculty of Pharmacy examination Board to monitor of the results of all the departments.

7. Chairman of the department of Applied Therapeutics scholarship committee to select local graduates to be trained for PhD in USA, UK or Canada.

8. Member of the Faculty of the Pharmacy promotion and renewal of contract committee for all the departments.

9. Review and Evaluation of the Performance of Department Chairmen of the Pharmacy and Medical Faculties.

10. Chairman of the Promotion-Revision Committee for Full Professor, Pharmacy Practice.

11.Chairman of the Selection Committee for the Chairman of Pharmaceutical Chemistry.

6


12. Member of the distinguished teaching and research awards of the staff of the Faculty of Pharmacy.

V-A. Honorary Advisor and Editor:

1. International Journal of Pharmacology and Pharmaceutical technology (India) from 2012 to date

V-B. REGIONAL EDITOR FOR MIDDLE-EAST

1. Inflammopharmacology (UK) from 2006 to date.

V- C. EDITORIAL AND ADVISORY BOARD MEMBER OF INTERNATIONAL JOURNALS

1. Agents and Actions (Inflammation Research) (Switzerland): Editorial Board Member from 1989 to 1992.

2. Experimental and Toxicologic Pathology (Formerly Experimental Pathology) (Germany): Advisory Board member from 1989 to 1996.

3. International Journal of Tissue Reactions (Switzerland): Editorial Board member from 1994 to 2005.

4. Asia Pacific Journal of Pharmacology (Singapore): Editorial Advisory Board Member from 1995 to 2006.

5. Current Drugs Ltd. (U.K): Evaluator for the Investigational Drugs Database from 1994 to 1998.

6. Journal of Pharmacology and Toxicology, Technical Editor (Academic Journals net, USA) from 2007 to 2009

7. Pharmacy Times (USA): Middle East Editorial Board Member from 2007 to date.

8. Inflammopharmacology (UK): Editorial Advisory Board Member from 1997 to date.

9. International Journal of Immunopathology and Pharmacology (Italy) from 2006 to 2014.

10. European Journal of Inflammation (Italy) from 2006 to date.

11. Archives of Medical Research (Mexico City) from 2006 to date.

12. Clinical Medicine: Endocrinology and Diabetes (New Zealand) from 2008 to date.

13. Clinical Medicine: Therapeutics (New Zealand) from 2009 to date.

7


14. American Journal of Biomedical Sciences (USA) from 2009 to date.

15. Journal of Pharmaceutical Technology and Drug Research (UK) from 2011 to date.

16. Reviewer of Manuscripts for International Journals.

VI. ADVISORY BOARD MEMBER OF INTERNATIONAL CONFERENCES

1. International Kinin Conference: International Advisory Board member. Guaruja, Brazil,

1993.

2. 5th Intersciences World Conference on Inflammation, Antirheumatics, Analgesics,

Immunomodulators: International Advisory Board Member. Geneva, Switzerland, 1993.



4. 14th International Symposium of Kinin: International Advisory Board Member. Denver,

U.S.A., 1995.



6. The 15th International Conference on Kinin; International Advisory Board Member; Nara,

Japan, 1998.

7. 8th Annual Health Sciences Poster Day, Faculty of Medicine, Kuwait University, Kuwait,

2003.

VII. EDITORIAL BOARD MEMBER OF NATIONAL JOURNALS

1. Diagnosa (The Medical Bulletin of the School of Medical Sciences, Universiti Sains Malaysia)

Editorial Committee Member from 1992 to 1993.

2. Malaysian Journal of Medical Sciences: Editorial Board Member from 1993 to 1995.

VIII. REASEARCH GRANTS, AWARDS AND EXTERNAL ASSESSOR FOR

PROMOTION TO FULL PROFESSOR

1. Research grant: Kuwait University

8


Principal Investigator:

Clinical Priority research Grant No. PR 01/09; (Kuwait University) entitled “ Investigational study on bradykinin system and nitric oxide in healthy subjects, hypertensive and type -2 diabetic patients in Kuwait”. Total amount KD 41,595.00x US$3.60 for 4 years (2011 to 2015)

Co-investigators:

1. Dr. Kamal A. S. Al-Shoumer, Associate Professor, Department of Medicine, FoM.

2. Dr. Kamal Matar, Associate Professor, Department of Pharmacology and Therapeutics, FoP.

3. The British Council Overseas Student Fee’s Award. October 1974 to September 1976

4. Research Fellowship awarded by the Merck, Sharp and Dohme (U.K). October 1974 to

September 1976.

5. Post-doctoral Research Fellowship awarded by the Merck, Sharp and Dohme (U.K).

October 1976 to September 1978.

6. Fellowship award from the 1st world Conference on Clinical Pharmacology (London). June

1980.

7. Three Short –term Research Grants from Universiti Sains Malaysia, Penang, Malaysia.

September 1989 to August 1991 and April 1993 to March 1998 with the funding of M$

100000.00

8. Research And Development Grant (IRPA) Award from The Ministry of Science, technology

and Environment of Malaysia. From January 1993 with the funding of M$ 400000.00.

9. A. External Assessor for Promotion to the rank of Full Professor: Dr. Abdul Rahman H.

Mohd. Noor, MBBCh, DCH, MSc, FRCP, Vice Dean , School of Medical Sciences,

University Science Malaysia, Kubang Kerian, Kelantan, Malaysia. February 14, 2009.

B. External Assessor for Promotion to the rank of Associate Professor: Dr. Sania Abdalla

Ibrahim Shadad, PhD, Assistant Professor of Pharmacology, Faculty of Pharmacy, University

of Khartoum, Khartoum, Sudan. March 17, 2009.

C. External Assessor for Promotion to the rank of Associate Professor: Dr. Abdullah M. Al-

Mohizea, PhD, Assistant Professor, College of Pharmacy, King Saud University, Riyadh,

Saudi Arabia. February 14, 2010.

9


D. External Assessor for Promotion to the rank of Associate Professor: Dr. Fahad Ibrahim

Abdul Rahman Al-Jenoohi, PhD, Assistant Professor, College of Pharmacy, King Saud

University, Riyadh, Saudi Arabia. 31 May, 2010.

E. External Assessor for Promotion to the rank of Full Professor: Dr. Fars Kaed Alanazi,

Associate Professor, PhD, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

27 September, 2011.

F. External Assessor for Promotion to the rank of Associate Professor: Dr Mohamed Abbas

Ibrahim Hamoud, PhD, Assistant Professor, College of Pharmacy, King Saud University,

Riyadh, Saudi Arabia. 7 June, 2012.

G. E. External Assessor for Promotion to the rank of Full Professor: Dr. Fahad Ibrahim Al-

Jenoobi, PhD, Associate Professor, College of Pharmacy, King Saudi University, Riyadh,

Saudi Arabia. April, 19, 2015.

IX. MEMBERSHIP OF PROFESSIONAL LEARNED SOCIETY

Member of the British Pharmacological Society of Great Britain.

Member of Canadian Society of Physiology and pharmacology.

Member of Canadian Society of Clinical Investigation (Canada).

Member of Malaysian Society of Pharmacology and Physiology

X. POSITIONS IN INTERNATIONAL CONFERENCES (ORAL SESSIONS)

• Chairman 26th Scientific Meeting of the Malaysia Society of Pharmacology and

Physiology. Poster Session. May 19, 2012.

• Chairman 25th Scientific Meeting of the Malaysia Society of Pharmacology and

Physiology. Symposia on Tissue Engineering. May 26, 2011.

• Chairman 15th International Conference on Kinins. October 19 – 24, 1998.

Nara, Japan.

10


• Chairman 7th Intersciences World Conference on Inflammation,

Antirheumatics, Analgesics, Immunomodulators. May 19 – 21, 1997.

Geneva, Switzerland.


Antirheumatics, Analgesics, Immunomodulators, March 28 – 30, 1995.


• Chairman Kinin International Congress. October 17 – 22, 1993. Guaruja,

Brazil.


Antirheumatics, Analgesic, Immunomodulators. April 25 – 28, 1993.


• Chairman The International Conference on the Use of Traditional

Medicine and Other Natural Products in Health-Care. June 8 – 11, 1993.


• Chairman Kinin International Conference Towards Understanding the

Molecular Basis of Kinin Actions. September 8 – 14, 1991. Munich,

Germany.


Antirheumatics, Analgesics, Immunomodulators. April 15 – 18, 1991.


• Chairman 3rd Intersciences World Conference on Inflammation,

Antirheumatics, Analgesics, Immunomodulators. March 15 – 18, 1989.

Monte Carlo

• Chairman Kinin International Conference, November 29 – December 3,

11


1987. Tokyo, Japan

XI. SPECIAL INVITED GUEST LECTURES AND PLENARY LECTURE

1. Department of Pharmacology, All- India Institute of Medical Sciences, New Delhi, India, July

1980.

Lecture: “The Kallikrein –Kinin System”.

2. Symposium on Renal function, Hypertension and Kallikrein-Kinin System: Satellite

Symposium of International Kinin Conference, Sapporo, Japan, December 1987.

Lecture: “the Kallikrein- Kinin System and Hypertension”.

3. Department of Pharmacology, All –India Institute of medical Sciences, New Delhi, India, May

1989.

Lecture: “Involvement of Kinin in the Action of Angiotensin Converting Enzyme Inhibitors”.

4. 8th Scientific meeting of the Malaysian Society of Pharmacology and Physiology, Penang,

Malaysia, July 1989.

Lecture: “ The Kinin System in Hypertension and Inflammation”

5. International Kinin Conference, Munich, Germany. September 1991.

Lecture: “Involvement of the Kinin –Forming System in the Genesis of Joint Inflammatory

Disease”.

6. Department of Surgery, Queen’s University Medical School, Kingston, Ontario, Canada,

December1991.

Lecture: “The Role of Kallikrein - Kinin System in the Genesis of Joint Inflammatory

Disease”

7. Division of Basic Medical Sciences, Faculty of Medicine, Memorial University of

Newfoundland, St. John’s, Canada, December 1991.

Lecture: “The Kallikrein – Kinin System in Blood Pressure Regulation”.

8. School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia,

May 1992.

12


Professorial Public Lecture: “Significance of Bradykinin in Health and Disease”.

9. 11th Iranian Congress of Physiology and Pharmacology, Tabriz University of Medical

Sciences, Tabriz, Iran, May 1993.

Lecture: “The Role of Kallikrein- Kinin System in Hypertensive Disease”.


Immunomodulators, Geneva, Switzerland, May 1997.

Lecture: “Cardioprotective Effects of Kinin System and its Role in Inflammation”

11. Postgraduate Seminar in Cardiovascular Therapeutics, Universiti Sains Malaysia, Penang,

Malaysia, November 1997.

Lecture: “Significance of Kallikrein- Kinin System in Hypertension”.

12. International Conference of Stress, Prophylaxis and Treatment, Calcutta, India, January

1998.

Lecture: “Kallikrein – KininSystem in Hypertension and Diabetes”.

13. Asthma in the 1990s: Current Insights and Future Outlook, Penang, Malaysia, October 1998.

Lecture: “Inflammatory Mediators in Asthma”

14. Rheumatology update symposium, Faculty of Medicine, Kuwait University, Kuwait, January

2001.

Lecture: “Drugs used in Patients with Common Rheumatic Diseases”.

15. International Conference on Inflammopharmcology 2003, Royal College of Physicians of

Edinburgh, Scotland. April 2003.

Lecture: “Recent advances in the kallikrein-kinin system in inflammatory disorders”.

16. 7th International Symposium on Pharmaceutical Sciences, Ankara University Faculty of

Pharmacy, Ankara, Turkey, June 2003.

Lecture: “Significance of the kinin system in the cardiovascular disorders.

17. The Philippines Society of Experimental and Clinical Pharmacology Meeting, Faculty of

13


Medicine and Surgery, Department of Pharmacology, University of Santo Tomas, Manila,

Philippines, May 2004.

Lecture: “The kallikrein-kinin system in cardiovascular disorders- a new therapeutics

modality found?

18. 20th Federation of the Asian Pharmaceutical Association Congress, Bangkok, Thailand,

November 30 – December 3, 2004.

Lecture: “Bradykinin agonists in the treatment of cardiovascular disorders”.

19. 20th Scientific meeting of the Malaysian Society of Pharmacology and Physiology, Penang,

Malaysia, April 25-29, 2005.

Plenary lecture: “The role of nutraceuticals in therapeutics: myth or reality.

20. Faculty of Pharmacy, Chiang Mai University, Thailand, June 11-14, 2006.

Guest lectures: Important roles of the kinin-forming components in cardiovascular and

inflammatory conditions, and the role of nutraceuticals in therapeutics: myth or reality.

21. 4th Asian Association of Schools of Pharmacy and 9th Malaysian Pharmaceutical Society

Pharmacy Scientific Conference 2009 , Penang, Malaysia, June 10-13, 2009.

Invited Lecture: “Role of the bradykinin system in hypertension: Prospects for future drug

Therapy.

22. 24th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology, Shah

Alam, Kuala Lumpur, Malaysia, June 2-3, 2010.

Special Lecture: Bradykinin system and rheumatoid arthritis: An overview.

23. 25th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology, Serdang,

Selangore, Malaysia, May 25 - 26, 2011.

Plenary Lecture: Kallikrein-kinin pathway in cardiovascular and renal systems: possibility for

new drug development.

24. 26th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology,

Penang, Malaysia, May 18 - 20, 2012.

Plenary Lecture: Bradykinin system: Role in hypertension and diabete.

14


25. 27th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology,

Kuantan, Malaysia, September 6 - 8, 2013.

Plenary Lecture: Kallikrein-kinin pathways in cardio-renal system: prospect of new drug

development.

XII. RESEARCH AND DEVELOPMENT AREAS

Supervision of Research Projects for Higher Degrees

1. Ph.D. (Doctor of Medical Science) under the Japanese Society for Promotion of

Science.

Research work on the “The role of Kallikrein – Kinin System in Experimental

Hypertension”.

Candidate’s name: S.S.J. Mohsin, B.Sc,. M.Sc. (Australia), Associate

Professor and Ex-Head of Pharmacology, School of Medical Sciences,

Universiti of Sains Malaysia. The degree was awarded in March 1992

from the Kitasato University School of Medicine, Kanagawa, Japan.

2. M.Sc. By Research work on “Pharmacological Studies of Some Mediators on

Guinea –Pig Tracheal Smooth Muscle”.

Candidate’s Name: Dr. Akbar Ali, M.B.B.S. (Rangoon). Completed in 1994.

3. M.Sc. By Research work on “The studies on Kallikrein –Kinin System in Normotensive and

Hypertensive Rats with and without Diabetes”.

Candidate’s Name: Dr. K. Uma, M.B.B.S. (Madras). Completed in 1995.

4. M.Sc. By Research work on “Role of the Kallikrein System in Cardiac Arrhythmias induced

by Coronary Artery Ligation in Rats”.

Candidate’s name: S. Atif Abbas, B.Pharm. (Pakistan). Completed in 1999.

5. M.Sc. By Research work on “Anti-Inflammatory Activity of the Fractinated Extract of Plant

Crinum Asiaticum (Family: Amaryllidacene)”.

15


Candidate’s name: A. Mabruk Samud, B.Pharm. (Libya). Completed in 1998.

Short – Term University Research Grants (1989 – 1991 and 1993 – 1994 – 1998)

1. Role of Kinin System in experimental arthritis

2. Role of Kinin System in experimental hypertension.

3. Involvement of Kallikrein – Kinin System in experimental epilepsy.

Long – Term Research Development Grant from the Ministry of Science, Technology and

Environment Malaysia

1. Investigations on the role of humoral factors with the emphasis on the Kallikrein – Kinin

System experimental models (1993 – 1995).

a. Hypertension

b. Inflammatory Joint disease

c. Asthma

2. Studies on cardiac and renal Kallikrein –Kinin System in Hypertension (1997 – 1999).

Personal Research and Development

1. Critical evaluations of the molecular actions of Kallikreins–Kininogens-Kinins–Kininases

System and its interactions with arachidonic acid products, platelet activating factor,

cytokines and products released by endothelial cells in experimental hypertension,

inflammation, asthma and diabetes.

2. Contributions of the Kallikreins-Kininogens-Kinins-Kininases and related agents in the

pathophysiology of inflammation and cardiovascular-renal disorders with special reference

to hypertension and diabetes.

3. Evaluations of the mode of actions of antihypertensive agents dependant upon the Kallikrein

– Kinin System.

4. Mechanism of actions and toxicity of anti-inflammatory agents with reference of

cardiovascular, gastrointestinal, renal and airway systems.

5. Blood pressure regulation by the Kallikrein-Kinin System, and its role in the pathophysiology

of left ventricular hypertrophy in the presence of hypertension.

6. Endogenous agents in regulation of tracheal smooth muscle in experimental and clinical

asthma.

16


7. Kallikrein – Kinin System in experimental and clinical diabetes.

International Research Collaboration

1. Professor M. Katori, Department of Pharmacology, Kitasato University, School of Medicine,

Kitasato, Kanagawa, Japan.

2. Professor J.M. Stewart, Department of Biochemistry, School of Medicine, University of

Colorado, Health Sciences Center, Denver, U.S.A.

3. Associate Professor K.C. Srivastava, Department of Environmental Medicine Institute of

Community Health, Odense University, Odense, Denmark.

4. Dr. K. Wirth, Hoechst AG, SBU Cardiovascular Agents, Frankfurt (Main), Germany.

5. Professor E.K. Gan, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang,

Malaysia.

XIII. EXAMINER FOR PH.D. THESES

1. Ph.D. Theses Examiner, Department of Pharmacology, Faculty of Medicine, National

University of Malaysia, Kuala Lampur, Malaysia. January 1992.

2. Ph.D. Thesis Examiner, Department of Pharmacology, Faculty of Medicine, National

University of Malaysia, Kuala Lumpur, Malaysia. February 1994.

XIV. TEACHING

Undergraduate (M.D., M.B.Ch.B. and B.Pharm (Hons)).

1. Problem Based Learning and Fixed Modules learning to 2nd and 3rd year M.D. and B.

Pharm. (Hons) students in the Integrated System of Education.

2. A course of lectures and tutorials on Physiological and Pharmacological Basis of

Therapeutics to 1st, 2nd, and 3rd year, 4th year and 5th year M.D. and B.Pharm.

3. Problem coordinator for Respiratory Block and Coordinator for Central Nervous System

to M.D. and B. Pharm.

4. Practical classes on pharmacological experiments.

17


5. Elective topics on non-medical curriculum related subjects and research elective on

Advanced Therapeutics for M.D. and B.Pharm. Courses.

6. Pharmacological Basis of Therapeutics of Renal, Respiratory, Blood, Cardiovascular,

Central Nervous System, Gastrointestinal System, Autacoids Pharmacology, General

Pharmacology, Anti-Microbial, Endocrine Pharmacology, Autonomic Pharmacology,

Dermatology and Rheumatology

7. Course coordinator of Applied Therapeutics courses of B. Pharm. Pharmacy programs

432, 531 and 533.

8. Patients Case Based Teaching of Applied Therapeutics to B.Pharm. 432 and 533.

9. Pathophysiology and Chemotherapeutics to B.Pharm.

Nursing and Medical Technologists

1. Course of lectures on Pharmacology.

2. Practical classes in experimental pharmacology.

Postgraduate

1. Co-coordinator of the Department of Pharmacology to 1st year M.Med. (Master of

Medicine) students in Internal Medical, Pediatrics and Surgical Base Disciplines.

September 1988 – 1996.

2. Board Member of the Postgraduate Research and Development Committee of the School

of Medical Sciences, Universiti Sains Malaysia. July 1988 – 1996.

3. Lectures or courses of lectures to Master of Medicine and Master of Pharmacy students

in Medical and Surgical Base Departments.

4. Chairman of the Continuity Medical Education, School of Medical Sciences, Universiti

Sains Malaysia. February 1995 to Dec 1996.

5. Supervision of Ph.D. and M.Sc. research projects.

18


XV- A. BOOK:

1. Jagdish N. Sharma (2011). “Topics in Mediators Pharmacology” 1st Edition, Nova Science

Publishers, Inc., New York, USA

2. Jagdish N. Sharma (2014). Progress in Drug Research: Recent Developments in the

Regulation of Kinins (Editor). Volume 69. Editor. Springer International Publisher, Basel,

Switzerland.

XV-B. FULL PUBLICATIONS:

109. Sharma , J. N. and Narayanan, P. ( 2015 ). Basic pharmacology of bradykinin

receptor agonists. Austin Journal of Pharmacology and Therapeutics (USA) 3: 1070

108. Sharma, J. N. , Al-Shoumer, K. A. S., Matar, Madathil, N. V. and Al-Moalem, A.M.K. ( 2015 ).

Altered activities of kininsae II, an angiotensin converting enzyme, prekallikrein

and nitric oxide in Kuwaiti patients with type 2 diabetes. International Journal of

Immunopathology and Pharmacology (Italy) 28: 240-246.

107. Sharma, J. N. (2014). Basic and clinical aspects of bradykinin receptor

antagonists. In “ Progress in Drug Research: Recent Developments in the Regulation of

Kinins. Volume 69. Edited by J. N. Sharma, Springer International Publisher, Basel,

Switzerland. pp. 1-14.

106. Sharma, J. N. and Narayanan, P. (2014). The kallikrein-kinin pathways in

hypertension and diabetes.. In “ Progress in Drug Research: Recent Developments in the

Regulation of Kinins. Volume 69. Edited by J. N. Sharma, Springer International Publisher,

Basel, Switzerland, pp.15-36.

105. Sharma, J. N. , Al-Shoumer, K. A. S., Matar, K. M., Al-Gharee, H. Y. and Madathil, N. V.

(2013). Bradykinin-forming components in Kuwaiti patients with type 2 diabetes.

International Journal of Immunopathology and Pharmacology (Italy) 26: 699-705

19


104. Sharma, J. N. (2013). The kinin system in hypertensive pathophysiology.

Inflammopharmacology (UK) 21: 1-9

103. Sharma, J. N. (2012). Association between the kinin-forming system and

cardiovascular pathophysiology. Asia Pacific Journal of Tropical Biomedicine (China)

2 (Supplement 3): S1938-S1944.

102. Sharma, J. N. and Al-Banoon, A. (2012). The role of inflammatory mediator brabykinin in

cardiovascular and renal system. Open Access Scientific Report. 1: 142.doi:104172

101. Sharma, J. N. and Narayanan, P. (2011). Hypertension and Diabetes: Contribution

of the kallikrein-kinin system. Journal of Diabetes and Metabolism (USA) S4:004.

doi:10.4172/2155- 6156. S4-004.

100. Sharma, J. N. and Kesavarao, U. (2011). The effects of captopril on cardiac

regression, blood pressure and bradykinin components in diabetic Wistar Kyoto rats.

International Journal of Immunopathology and Pharmacology (Italy) 24: 337-343.

99. Sharma, J. N. and Al-Sherif, G. J. (2011). The kinin system: present and future

pharmacological targets. American Journal of Biomedical Sciences (USA) 3: 156-169.

98. Sharma, J. N. (2010). Activation of bradykinin system by angiotensin- converting

enzyme inhibitors. European Journal of Inflammation (Italy) 8: 55-61.

97. Sharma, J. N. (2010). Modification in tissue kallikrein activity with indomethacin

and prednisolone treatment in arthritic rats. Inflammopharmacology (UK) 18: 113-117.

96. Sharma, J. N. (2009). An overview on relation between the bradykinin system and

hypertension and diabetes. American Journal of Biomedical Sciences (USA) 1: 242-249.

95. Sharma, J. N. (2009). Hypertension and the bradykinin system. Current

Hypertension Reports (USA) 11: 178-181.

94. Sharma , J. N. (2009). The kallikrein-kinin pathways in mediating the

20


hypotensive action of angiotensin converting enzyme (ACE) inhibitors. In “ Angiotensin

Converting Enzyme Inhibitors” Edited by A. N. DeBrue. Nova Science Publishers (USA)

pp. 185-198.

93 Sharma, J. N. (2008). Cardiovascular activities of the bradykinin system.

The Scientific World Journal (USA) 8: 384-393.

92. Sharma, J. N., Kadir, Z. and Uma, K. (2008). Evaluation of inflammatory kinin-forming

components in experimental epilepsy in rats. Inflammopharmacology (UK) 16: 151-153.

91. Sharma, J. N. (2007). The bradykinin system: role in cardiovascular and

and diabetic pathophysiology. Current Topics in Pharmacology (India) 11: 91-100.

90. Sharma, J. N., Al-Omran, A and Parvathy, S. S. (2007). Role of nitric oxide in

inflammatory diseases. Inflammopharmacology (U.K.) 15: 252-259

89. Sharma, J. N. and Kesavarao, U. (2007). Changes in plasma prekallikrein activity,

blood pressure and left ventricular thickness in hypertensive and normotensive diabetic

rats. Methods and Findings in Experimental and Clinical Pharmacology (Spain) 29: 75-

78.

88. Sharma, J. N. (2007). The kinin-forming system and cardiovascular disorders. Journal

Salud (i) Ciencia (Argentina) 15: 972-976.

87 . Sharma, J. N. and Al-Sherif, G. J. (2006). Pharmacologic targets and prototype

therapeutics in the kallikrein-kinin system: Bradykinin receptor agonists or antagonists.


86 Sharma, J. N. and Abbas, S. A. (2006). Effect of captopril in the presence of

Kinin B2-receptor antagonist on the duration of survival after prolonged coronary

artery ligation in hypertensive rats. Methods and Findings in Experimental and

Clinical Pharmacology (Spain) 28: 217-221.

85 Sharma, J. N. (2006). Is there a place for bradykinin agonists in therapy of

21


cardiovascular disorders? Journal of Pharmacology and Toxicology (USA)

1: 12-18.

84 Sharma, J. N. and Mohammed, L. A. (2006). The role of leukotrienes in

pathophysiology of inflammatory disorders: Is there a case for revisiting

leukotrienes as therapeutic targets? Inflammopharmacology (UK) 14: 10-16.

83 Sharma, J. N. (2006). Role of tissue kallikrein-kininogen-kinin pathways in

cardiovascular system. Archives of Medical Research (USA) 37: 299-306

.

82 Sharma, J. N. and Jawad, N. M. (2005). Adverse effects of COX-2 inhibitors.


81 Sharma, J. N. and Abbas, S. A. (2005). A bradykinin antagonist abolishes

beneficial effect of captorpril on duration of survival after acute coronary artery

ligation in hypertensive rats. Pharmacological Research (UK) 52: 211-215.

80 Sharma, J. N. (2005). The kallikrein-kinin system: From mediator of inflammation to

modulator of cardioprotection. Inflammopharmacology (UK) 12: 591-596.

79 Sharma, J. N. and Thani R. B. (2004). Therapeutic prospects of bradykinin receptor

agonists in the treatment of cardiovascular diseases. Investigational Drugs Journal

(IDrugs) (UK) 7: 926-934

78 Sharma, J. N. (2004). Bradykinin agonists in the treatment of cardiovascular disorders.

In the “Proceeding of the 20th Federation of the Asian Pharmaceutical Association

(FAPA) Congress; Edited by Srianujata, S.; Bangkok, Thailand. pp 1-6.

77 Sharma, J. N., Samud, A. M. and Asmawi, M. Z. (2004). Comparison between

plethysmometer and micrometer methods to measure acute paw oedema for scrining

ant-inflammatory activity in mice. Inflammopharmacology (UK) 12: 89-94

76 Sharma, J. N., Abbas, S. A., Yusof, A. P. M., Shah, R. P. and Gan, E. K. (2004). Tissue

kallikrein increases survival after prolonged coronary artery ligation in hypertensive

rats. Pharmacology (Basel) 70: 201-205

22


75 Sharma, J. N. (2003). Does the kinin system mediate in cardiovascular abnormalities?

An overview. The Journal of Clinical Pharmacology (USA) 43: 1187-1195.

74 Sharma, J. N. and Al-Dhalmawi, G. (2003). Bradykinin receptor antagonists: therapeutic

implications. Investigational Drugs Journal (IDrugs) (UK) 6: 581-586.

73 Sharma, J. N., Abbas, S. A., Yusof, A. P. M. and Shah, R. P. (2003). Evaluation of tissue

kallikrein activity on survival time after acute coronary artery ligation in hypertensive

rats. International Immunopharmacology (USA) 3: 329-334.

72 Sharma, J. N. and Uma, K. (2002). Effect of Captopril on Urinary Kallikrein, Blood

Pressure and Myocardial Hypertrophy in Diabetic Spontaneously Hypertensive Rats.

Pharmacology (Basel) 64: 196- 200.

71 Sharma, J. N. and Sharma, J. (2002). Cardiovascular Properties of the Kallikrien- Kinin

System. Current Medical Research and Opinion (Lond.) 18: 10- 17.

70 Sharma, J. N., Zubaid, M., Khan, B. Z. S. J., Yusof, A.P.M. and Asmawi, M. Z. (2000).

Pathophysiological activities of the Kallikrien- Kinin System with emphasis on the

cardiovascular disorders. Inflammopharmacology (UK) 8: 219- 241.

69 Sharma, J. N. (2000). Kinin System in Protecting the Heart. In “National Symposium on

Health Sciences Proceeding”, Edited by K.L. Yap et al. Kuala Lumpur, Malaysia. PP.

381- 384.

68 Sharma, J. N., Kesavarao, U. and Yusof, A.P.M. (1999). Altered Cardiac Tissue and

Plasma Kininogen levels in Hypertensive and Diabetic Rats. Immunopharmacology 43:

129- 132.

67 Abbas, S.A., Sharma, J.N. and Yusof, A.P.M. (1999). The Effect of Bradykinin and Its

Antagonist on Survival Time After Coronary Artery Occlusion in Hypertensive Rats.

Immunopharmacology (The Netherlands). 44: 93 – 98.

66 Samud, A.M., Asmawi, M.Z., Sharma, J.N. and Yusof, A.P.M. (1999). Anti-inflammatory

Activity of Cranum Asiaticum Plant and Its Effect on Bradykinin Induced Contractions

on Isolated Uterus. Immunopharmacology. (The Netherlands). 43: 311 – 316.

23


65 Abbas, S.A., Sharma, J.N. and Yusof, A.P.M. (1999). Effect of Bradykinin and Its

Antagonist on Survival Time After Coronary Artery Occlusion in Rats. General

Pharmacology (USA). 33: 243 – 247.

64 Sharma, J.N. and Yusof, A.P.M. (1998). Proinflammatory Properties of the Kallikrein –

Kinin System: Potential for new Drugs Therapy. Inflammopharmacology (The

Netherlands) 6: 286 – 296.

63 Akbar, A., Sharma, J.N., Yusof, A.P.M. and Gan, E.K. (1998). Potentiation of Bradykinin

Induced Responses by Indomethacin in Intact and Denuded Epithelium of Guinea-Pig

Tracheal Preparations. International Journal of Tissue Reactions (Geneva). XX: 95 –

100.

62 Sharma, J.N., Uma, K. and Yusof, A.P.M. (1998). Left Ventricular Hypertrophy and Its

Relation to Cardiac Kinin-Forming System in Hypertensive and Diabetic rats.

International Journal of Cardiology (U.K.) 63: 229 – 235.

61 Sharma, J.N., Yusof, A.P.M. and Wirth, K.J. (1998). The Kinin antagonist Hoe 140

Reduces Paw Oedema in rats Caused by Carrageenan, Bradykinin and Kaolin.

Inflammopharmacology (The Netherlands) 6: 9 – 17.

60 Sharma, J.N., Yusof, A.P.M. and Ishak, F.I. (1997). Significance of the Kinin System in

Pathophysiology of Inflammatory Joint Diseases. In “Proceedings of the 16th Asian

Congress of Pharmaceutical Sciences”. Edited by Hussin, A.H., Ibrahim, M.I.M. and

Awang, R. Malaysian Pharmaceutical Society, Kuala Lumpur, pp. 140 – 145.

59 Sharma, J.N., Ishak, F.I., Yusof, A.P.M. and Srivastava, K.C. (1997). Effects of Eugenol

and Ginger Oil on Adjuvant Arthritis and the Kallikrein in Rats. Asia Pacific Journal of

Pharmacology (Singapore) 12: 9 – 14.

58 Sharma, J.N. and Yusof, A.P.M. (1997). Cardioprotective Effects of Kinin System and its

role in Inflammation. International Journal of Tissue Reactions (Geneva) 19: 53.

57 Sharma, J.N. and Kesavarao, U. (1996). Cardiac Kallikrien in Hypertensive and

Normotensive Rats with and without Diabetes. Immunopharmacology (The

Netherlands) 33: 341 – 343.

24


56 Sharma, J.N. and Wirth, K.J. (1996). Inhibition of rats Adjuvant Arthritis by a Bradykinin

Antagonist Hoe 140 and its Influence on Kallikrein. General Pharmacology (U.S.A.) 27:

133 – 136.

55 Sharma, J.N., Uma, K., Noor, A.R. and Rahman, A.R. (1996). Blood Pressure Regulation

by the Kallikrein-Kinin System. General Pharmacology (U.S.A.) 27: 55 – 65.

54 Sharma, J.N., Amrah, S.S. and Noor, A.R. (1995). Suppression of Hypotensive

Responses of Captopril and Enalapril by kallikrein Inhibitor Aprotinin in Spontaneously

Hypertensive Rats. Pharmacology (Basel) 50: 363 – 369.

53 Sharma, J.N., Srivastava, K.C. and Gan, E.K. (1994). Suppressive Effects of Eugenol and

Ginger Oil on Arthritic Rats. Pharmacology (Basel) 49: 314 – 318.

52 Sharma, J.N., Amrah, S.S. and Srivastava, K.C. (1994). Anti-inflammatory Properties of

Eugenol and Ginger Oil in Rat Arthritis Induced by Mycobacterial Adjuvant. In “Trends

in Traditional Medicine Research”. Edited by Chan, K.L., Hussin, A.H., Yuen, K.H.,

Asmawi, M.Z. and Ismail, Z., School of Pharmaceutical Sciences, Universiti Sains

Malaysia, Penang, Malaysia. pp.298 – 302.

51 Sharma, J.N. and Buchanan, W.W. (1994). Pathogenic Responses of Bradykinin System

in Chronic Inflammatory Rheumatoid Disease. Experimental and Toxicologic Pathology

(Germany) 46: 421 – 433.

50 Sharma, J.N. (1993). Therapeutic Prospects of Bradykinin Receptor Antagonists.

General Pharmacology (Lond.) 24: 267 – 274.49 Sharma, J.N., Stewart, J.M., Mohsin, S.S.J., Katori, M. and Vavrek, R. (1992). Influence of a

Kinin Antagionist on Acute Hypotensive Responses Induced by Bradykinin and

Captopril in Spontaneously Hypertensive Rats. Agents and Actions 38 (Suppl.III): 258 –

269.

48 Sharma, J.N. (1992). Involvement of the Kinin – Forming System in the

Physiopathology of Rheumatoid Inflammation. Agents and Actions 38 (Suppl. III): 343 –

361.

25


47 Mohsin, S.S.J, Majima, M., katori, M. and Sharma, J.N. (1992). Important Suppressive

Roles of the kallikrein – Kinin System During the Developmental Stage of Hypertension

in the Spontaneously Hypertensive Rats. Asia Pacific Journal of Pharmacology

(Singapore) 7: 73 – 82.

46 Akbar, A. and Sharma, J.N. (1992). Influence of Indomethacin on Histamine –and-

Acetylcholine- Induced Responses in the Intact and Denuded Epithelium of Guinea –

Pig Tracheal Smooth Muscle. Pharmacological Research (Lond.). 25: 279 – 286.

45 Sharma, J.N. (1991). Pro-Inflammatory Actions of Platelet Activating Factor: Relevant

to Joint Inflammatory disease. Experimental Pathology (Jena) 43: 47 – 50.

44 Sharma, J.N. (1991). The Role of Kinin System in Joint Inflammatory Disease.

European Journal of Rheumatology and Inflammation (Lond.) 11: 30 – 36.

43 Sharma, J.N. (1991). The Role of Kallikrein –Kinin System in Joint Inflammatory

Disease. Pharmacological Research (Lond.) 23: 105 – 112.

42 Sharma, J.N. (1990). Does Kinin Mediate the Hypotensive Action of Angiotensin

Converting Enzyme (ACE) Inhibitors? General Pharmacology (Lond.) 21: 451 – 457.

41 Sharma, J.N. and Mohsin, S.S.J. (1990). The Role of Chemical mediators in

Pathogenesis of Inflammation with Emphasis on the Kinin System. Experimental

Pathology (Jena) 38: 73 – 96.

40 Sharma, J.N. (1989). Contribution of Kinin System to the Antihypertensive Action of

Angiotensin Converting Enzyme Inhibitors. Advances in Experimental Medicine and

Biology (New York) 247A: 197 – 205.

39 Sharma, J.N. (1988). The Kinin System and Prostaglandins in the Intestine.

Pharmacology and Toxicology (Acta Pharmacologica et Toxicologica) (Copenhagen)

63: 310 – 316.

38 Sharma, J.N., Zeitliln, I.J., Mackenzie, J.F. and Russell, R.I. (1988). Plasma Kinin –

Precursor levels in Clinical Intestinal Inflammation. Fundamental and Clinical

Pharmacology (Paris) 2: 399 – 403.

26


37 Sharma, J.N., (1988). The Kallikrein –Kinin System and Hypertension in “Renal

Function, Hypertension and Kallikrein – Kinin System”. Edited by limura, O. and

Margolius, H.S. University of Tokyo Press, Tokyo, pp. 147 – 154.

36 Sharma, J.N. (1988). Interrelationship Between the Kallikrein-Kinin System and

Hypertension. A review, General Pharmacology (Lond.)19: 177 – 187.

35 Alhaboui, H.A., Bennett, D., Sharma, J.N., Thomas, G.R. and Zeitliln, I.J. (1986). A Synovial

Amidase Acting on Tissue Kallikrein- Selective Substrate in Clinical and Experimental

Arthritis. Advances in Experimental Medicine and Biology (New York) 198B: 405 – 411.

34 Sharma, J.N. (1986). Kallilkrein – Kinin System and Prostaglandin Interactions:

Relevant to hypertension. Pharmacological Research Communications (Lond.) 18: 639

– 652.

33 Sharma, J.N. (1984). Kinin –forming System in the Genesis of Hypertension. Agents

and Actions (Basel) 14: 200 – 205.

32 Sharma, J.N., Fernandez, P.G. and Triggle, C.R. (1984). The Effect of Indomethacin on

the duration of Hypotensive Action of Bradykinin in Dahl Salt – Resistant Rats: Role of

cyclo-oxygenase inhibition. Prostaglandins Leukotrienes and Medicine (Edinburgh) 14:

131 – 135.

31 Sharma, J.N., Fernandez, P.G., Laher I. And Triggle C.R. (1984). Differential Sensitivity of

Dahl Salt – Sensitivity and Salt – Resistant rats to the Hypotensive Action of Acute

Nifedipine Administration. Canadian Journal of Physiology and Pharmacology 62: 241

– 243.

30 Sharma, J.N., Fernandez, P.G., Kim, B.K. and Triggle, C.R. (1984). Systolic Blood

pressure Responses to Enalapril Maleate (MK – 421), an angiotensin converting enzyme

inhibitor and Hydrochlorothiazide in Conscious Dahl Salt Sensitive (S) and Resistant

(R) Rats. Canadian Journal of Physiology and Pharmacology 62:846 – 849.

29 Sharma, J.N. (1983). Ability of Prostaglandins to induce Acute Inflammatory Bowel

Disease in the Rats. A preliminary report. Journal of Medicine (New York) 14: 157 –

160.

27


28 Fernandez, P.G., Kim, B.K., Galway, A.B. and Sharma, J.N. (1983). Separation of Essential

Hypertensive Patients based on Blood Pressure Responses after the withdrawal of

Antihypertensive Agent by Stepwise Discriminent Analysis. Current Medical Research

and Opinion (Lond.) 8: 509 – 517.

27 Sharma, J.N., Fernandez, P.G., Kim, B.K., Edikio, H. and Triggle, C.R. (1983). Cardiac

Regression and Blood pressure Control in the Dahl Rat Treated with Enalapril Maleate

(MK – 421), an angiotensin converting enzyme. Journal of Hypertension (Lond.) 1: 251

– 256.

26 Sharma, J.N., Zeitlin, I.J., Deodhar, S.D. and Buchanan, W.W. (1983). Detection of

Kallikrein-Like Activity in Inflamed Synovial Tissue. Archives Internationales de

Pharmacodynamie et de Therapie (Ghent) 262: 279 – 286.

25 Fernandez, P.G., Sharma, J.N., Galway, A.B., Campbell, N., Kim, B.K., Snedden, W.,

Granter, S., MacDonald, J. and Gill, V. (1982). Potassium Conservation with Amiloride

Hydrochlorothiazide (Modurate) in Thiazide Induced Hypokalemia in Hypertension.

Current Medical Research and Opinion (Lond.) 8: 120 – 127.

24 Snedden, W., Sharma, J.N. and Fernandez, P.G. (1982). A sensitive Assay Method of

Furosemide in Plasma and Urine by High-Performance Liquid Chromatography.

Therapeutic Drug Monitoring (New York) 4: 831 – 383

23 Fernandez, P.G., Sharma, J.N., Gallway, A.B., Kim, B.K., Granter, S. and Zachariah, P.K.

(1982). Comparison of Antihypertensive Efficacy: Propanolol Verses Oxprenolol in

Accelerated Hypertension. Pharmatherapeutica (Lond.) 3: 153 – 156.

22 Sharma, J.N. and Fernandez, P.G. (1982). Pharmacological Abnormality of the

Kallikrein-Kinin System in Hypertension. Medical Hypothesis (Edinburgh) 9: 379 – 384.

21 Sharma, J.N. and Zeitlin, I.J. (1982). Reduced Plasma Kininogen Concentration by

Prostaglandin E2 in rats. European Journal of Pharmacology (Amsterdam) 83: 119 –

121.

20 Sharma, J.N. and Zeitlin, I.J. (1981). Altered Plasma Kininogen in Clinical Hypertension.

28


Lancet (Lond.) 1: 1259 – 1260.

19 Sharma, J.N., Zeitlin, I.J., Brooks, P.M., Buchanan, W.W. and Dick, W.C. (1980). The Action

of Aspirin on Plasma Kininogen and Other Proteins in Rheumatoid Patients. Clinical

and Experimental Pharmacology and Physiology (Oxford) 7: 347 – 354.

18 Sharma, J.N. and Buchanan, W.W (1980). Some Modern Aspects of the Mode of Action

of Non-steroidal Anti-inflammatory Drugs. Pharmatherapeutica (Lond.) 2: 387 – 396.

17 Sharma, J.N. and Buchanan, W.W. (1979). Kinin System in clinical and Experimental

Rheumatoid Inflammation: Short review. Current Medical Research and Opinion

(Lond.) 6: 314 – 321.

16 Sharma, J.N. (1978). The Effect of Prostaglandins (PGE2 and PGF2) on Plasma

Kininogens Levels in the Rat. Biomedicine (Paris) 29: 292 – 293.

15 Sharma, J.N. and Zeitlin, I.J. (1977). Indomethacin in Low Concentration Potentiates the

Action of Some Spasmogens on the isolated Oestrous Rat Uterus. Journal of

Pharmacy and Pharmacology (Lond.) 29: 316 – 317.

14 Sharma, J.N. (1977). Changes in Biochemical Parameters Associated with Experimental

Arthritis in Rabbits. Biomedicine (The European Journal of Clinical and Biological

Research) (Paris) 27: 252 – 255.

13 Sharma J.N. and Sharma, J.N (1977). Comparison of Anti-inflammatory Activity of

Commiphora Mukul (an indigenous drug) with Phenylbutazone and Ibuprofen in

Experimental Arthritis Induced by Mycobacterial Adjuvant. Arzeneimittel Forschung

(Drug Research) (Germany) 27: 1455 – 1457.

12 Sturrock, R.D., Sharma, J.N. and Buchanan, W.W. (1977). Evidence of Rheumatoid

Arthritis in Ancient India. Arthritis and Rheumatism (U.S.A) 20: 42 – 44.

11 Zeitlin, I.J., Sharma, J.N., Brooks, P.M. and Dick, W.C. (1977). An Effect of Indomethacin

on raised Plasma Kininogen Levels in Rheumatoid Patients, In “Chemistry and Biology

of the Kallikrein – Kinin System in Health and Disease”. Edited by Pisano, J.J. and

Austen, K.F. United States Government Printing Office, Washington, D.C., pp. 483 – 486.

29


10 Sharma, J.N., (1976). Studies on Plasma Kinin Precursors in Rheumatoid Arthritis.

Ph.D. Thesis. The University of Strathclyde, Glasgow, Scotland, U.K.

9 Zeitlin, I.J., Sharma, J.N., Brooks, P.M. and Dick W.C. (1976). Raised Plasma Kininogen

levels in Rheumatoid Arthritis: Response to Therapy with Non-Steroidal Anti-

inflammatory Drugs. Advances in Experimental Medicine and Biology (New York) 70:

335 – 343.

8 Sharma, J.N., Zeitlin, I.J., Brooks, P.M. and Dick, W.C. (1976). A Novel Relationship

Between Plasma Kininogen and Rheumatoid Diseases. Agents and Actions (Basel) 6:

148 – 153.

7 Sharma, J.N., Zeitlin, I.J., Brooks, P.M. and Dick, W.C., (1975). Raised Plasma Kininogen

Levels in Rheumatoid Arthritis: Response to Idomethacin and Relationship to clinical

Indices. Annals of Rheumatic Diseases (Lond) 34: 464.

6 Brooks, P.M., Dick, W.C., Sharma, J.N. and Zeitlin, I.J. (1974). Changes in Plasma

Kininogen Levels Associated with Rheumatoid Arthritis. British Journal of Clinical

Pharmacology 1: 351 P

5 Sharma, J.N. Sharma, J.N. and Arora, R.B. (1973). Abnormal Pattern of Serum Proteins

and Alkaline Phosphatase Activity in Rheumatoid Arthritis and Indication of Liver

Dysfunction. Rheumatism 8: 142 – 147.

4 Sharma, J.N., Sharma, J.N and Arora, R.B. (1973). Arthritis and Liver Function.

Rheumatism 8: 119 – 128.

3 Sharma, J.N. (1972). Liver Functions is arthritis and their Modification Drugs: An

Experimental and Clinical Study. M. Sc. (Pharmacology) Thesis. The All India Institute

of Medical Sciences, New Delhi, India.

2 Sharma, J.N., Sharma J.N., Shastri H.D. and Arora, R.B. (1972). Beneficial Effect of

Fraction A of Gum Guggal in Arthritis. A clinical appraisal. Rheumatism. 8: 21 – 53

1 Sharma, J.N., Sharma, J.N. and Arora, R.B. (1972). Beneficial Effect of fraction A of Gum

Guggal in Arthritis and Liver Functions in Clinical and Experimental Arthritis.

Rheumatism (New Delhi) 7: 20 – 21.

30


XVI. ABSTRACTS AND PRESENTATIONS IN INTERNATIONAL AND NATIONAL

CONFRENCES:

1. Zeitlin, I. J., Sharma, J. N., Brooks, P. M. and Dick, W. C. (1974). An Effect of Indomethacin

on Raised Plasma Kininogen Levels in Rheumatoid Patients. Paper presented in the

Conference on “Chemistry and Biology of the Kallikrien- Kinin System in Health and

Disease”. Organized by the Fogarty International Center for Advanced Study in the

Health Sciences and the National Institute of Health, Bethesda, Maryland, U. S. A.

October 20- 23.

2. Brooks, P. M., Sharma, J. N., Zeitlin, I. J. and Dick, W. C. (1975). Plasma Kininogen and

Rheumatoid Disease. Scandinavian Journal of Rheumatology 4 (Suppl. 8): Abstract No.

094.

3. Zeitlin, I. J., Sharma, J. N., Brooks, P. M., and Dick, W. C. (1976). Raised Plasma Kininogen-

Levels in Rheumatoid Patients- Response to Therapy with Nonsteroidal Anti-

Inflammatory Drugs. Agents and Actions 6: 449.

4. Zeitlin, I. J., Sharma, J. N., Brooks, P. M., Dick, W. C., Mackenzie, J. F., Russell, R. I., Strong,

A. M. and Thomson, J. (1977). Changes in Plasma Kininogen Levels Associated with

Inflammatory Diseases. Scottish Medical Journal 22: 191.

5. Zeitlin, I. J., Sharma, J. N., Brooks, P. M. and Dick, W. C. (1978). Studies on the Systematic

Kinin System in Rheumatoid Arthritis. International Congress of Inflammation, Bologna,

Italy, pp. 198.

6. Sharma, J. N. (1980). Does Prostaglandin E2 Cause Release of Plasma Kinins in the Rat?

Arachidonic Acid Cascade Symposium (European Society of Biochemical

Pharmacology), Seventh Congress of the Polish Pharmacological Society, pp. 205.

31


7. Sharma, J. N., Fernandez, P. G., Kim, B. K., Triggle, C. R., Idikio, H. and Laher, I. (1983).

Blood Pressure control and Hypertensive Heart Changes in the Dahl (D) Rat: MK- 421 (an

angiotensin converting Enzyme inhibitor) Versus Hydrochlorothiazide. Clinical research

31: 335A.

8. Sharma, J. N., Fernandez, P. G., Kim, B. K., and Triggle, C. R. (1983). Antihypertensive

Efficacy of MK- 241 (an angiotensin converting enzyme inhibitor, ACEI) and

Hydrochlorothiazide (HTZ) in Conscious Dahl Sensitive (S) and Resistant (R) Rats.

Clinical Research 31: 335A.

9. Fenandez, P. G., Sharma, J. N., Kim, B. K., Triggle, C. R., Idikio, H. and Laher, I. (1983). Left

Ventricular Regression and Blood Pressure Control on the Dahl (D) Rat with MK- 421 (an

angiotensin converting enzyme inhibitor, ACEI) and Hydrochlorothiazide (HTZ). Clinical

Research 31: 332A.

10. Fernandez, P. G., Kim, B. K., Sharma, J. N., Indikio, H. and Triggle, C. R. (1983). Left

Ventricular Regression (LVR) in association with Blood Pressure Control in the Dahl

Model of Hypertensive Rats (DS and DR) Treated with Enalpril Maleate (MK- 241) (an

angiotensin converting enzyme inhibitor) or Hydrochlorothiazide (HTZ). Clinical and

Investigative Medicine 6 (Suppl. 2): 55.

11. Alhaboubi, A. H., Bannett, D., Sharma, J. N., Thomas, G. R. and Zeitlin, I. J. (1984). A

Synovial Amidase Acting on Tissue Kallikrein- Selective Substrate in Clinical

Experimental Arthritis. Presented in the International Kinin Conference, Savannah, GA

30912, U. S. A.

12. Sharma, J. N., (1987). Contribution of Kinin System to the Anti- Hypertensive Action of

Angiotensin Converting Enzyme Inhibitors (ACEIs). Kinin 1987 Tokyo International

Congress, pp. 25 (a- 1- 08).

13. Sharma, J. N. (1987). The Kallikrein- Kinin System and Hypertension. Satellite

Symposiums of International Kinin Congress in Sapporo, Japan, pp. 33.

32


14. Sharma, J. N. (1989). The Kallikrein- Kinin System (KKS) in Joint Inflammatory Disease.

3rd Intersciences World Conference on Inflammation, Antirheumatics, Analgesics,

Immunomodulators, Monte Carlo, pp. 26.

15. Sharma, J. N. (1989). The Kinin System in Hypertension and Inflammation Malaysian

Society of Pharmacology and Physiology, Penang, Malaysia. Abstract of Special Lecture

pp. S1- S2.

16. Sharma, J. N., Mohsin, S. S. J., Stewart, J. M., Vavrek, R. and Lockman, A. (1989). The Effect

of a New Synthetic Antagonist to Bradykinin (BK) on Acute Antihypertensive Action of

Captopril in Spontaneously Hypertensive Rats (SHR). Malaysian Society of

Pharmacology and Physiology, Penang, Malaysia. Abstract pp. C24.

17. A. Akbar, Sharma, J. N. and Mohsin, S. S. J. (1989). Influence of the Epithelium on

Responsiveness of Isolated Guinea- Pig Tracheal of Agents. Malaysian Society of

Pharmacology and Physiology, Penang, Malaysia. Abstract pp. C8.

18. Mohsin, S. S. J. and Sharma, J. N. (1989). Does the Kidney Release Hypotensive

Substance? Malaysian Society of Pharmacology and Physiology, Penang, Malaysia.

Abstract pp. C20.

19. Sharma, J. N. (1991). Participation of the Kallikrien- Kinin System in the Pathogenesis of

Inflammatory Joint Disease. 4th Intersciences World Conference on Inflammation,

Antirheumatics, Analgesics, Immunomodulators, Geneva, Switzerland. Abstract No. 66.

20. Sharma, J. N. (1991). Involvement of Kinin- Forming System in the Physiopathology of

Rheumatoid Inflammation. International Kinin conference towards Understanding the

Molecular Basis of Kinin Action, Munich. Abstract pp. 167.

21. Sharma, J. N., Stewart, J. M., Mohsin, S. S. J., Katori, M. and Vavrek, R. (1991). Influence of

a Kinin Antogonist on Acute Hypotensive Responses Induced by Bradykinin and

Captopril in Spontaneously Hypertensive Rats. International Kinin Conference Towards

Understanding the Molecular Basis of Kinin Action, Munich. Abstract pp. 346.

33


22. Sharma, J. N. (1993). Tissue and Plasma Kallikreins Activities in the Regulation of

Adjuvant Arthritis in Rats. Intersciences World Conference on Inflammation,

Antirheumatics, Analgesics, Immunomodulators, Geneva, Switzerland. Abstract No. 183.

23. Sharma, J. N. (1993). Inhibition of Adjuvant Inflammation in Rats by the Kinin Receptor

Antagonist Hoe 140. Intersciences World Conference on Inflammation, Antirheumatics,

Analgesics, Immunomodulators, Geneva, Switzerland. Abstract No. 184.

24. Sharma, J. N., Srivastava, K. C. and Mustafa, T. (1993). Ginger (Zingibar officinale) in

Rheumatism and Musculoskeletal Disorders. 5th Intersciences World Conference on

Inflammation, Antirheumatics, Analgesics, Immunomodulators, Geneva, Switzerland.

Abstract No. 123.

25. Sharma, J. N. (1993). The Role of Kallikrein- Kinin System in Hypertensive Disease. Guest

Lecture of the 11th Iranian Congress of Physiology and Pharmacology. Tabriz University

of Medical Sciences, Tabriz, Iran. Abstract No. L- 7.

26. Sharma, J. N. and Mohsin, S. S. J. (1993). Effect of a Bradykinin Antagonist on Adjuvant

Arthritis in Rats. 10th Scientific Meeting of the Malaysian Society of Pharmacology and

Physiology. Kelantan. Abstract No. A6. Asian Pacific Journal of Pharmacology 8 (Suppl.

2): S23.

27. Sharma, J. N. and Srivastave, K. C. (1993). Anti- inflammatory Properties of Eugenol and

Ginger Oil in Rats Arthritis Induces by Mycobacterial Adjuvant. The International

Conference on the Use of Traditional Medicine and Other Natural Products in Health-

Care, Penang, Malaysia. Abstract No. OA- 2.

28. Sharma, J. N. (1993). Alterations in Kallikreins Levels in Experimental Arthritis in Rats.

International Kinin Conference, Guaruja, Brazil. Abstract No. 9. 07.

29. Sharma, J. N. (1993). Altered Blood Pressure Responses to Converting Enzyme Inhibition

with Aprotinin- Induced Kallikrein- Kinin System Blockade in Spontaneously

Hypertensive Rats. International Kinin Conference, Guaruja, Brazil. Abstract No. 8. 12.

34


30. Sharma, J. N. (1993). Anti- inflammatory Activity of a Bardykinin Antagonist (Hoe 140) in

Rats Experimental Arthritis. International Kinin Conference, Guaruja, Brazil. Abstract No.

9. 06.

31. Sharma, J. N. (1994). Changes in Kallikreins Levels Associated with Adjuvant Arthritis in

Rats. Satellite Symposia of the XIIth International Union of Pharmacology Congress,

Montreal, Canada. Canadian Journal of Physiology & Pharmacology 72 (Suppl. 2): P1. 15,

pp. 39.

32. Sharma, J. N. (1994). Suppression of Hypotensive Responses of Captopril and Enalapril

by Kallikrien Inhibitor in Hypertensive Rats. Satellite Symposia of the XIIth International

Union of Pharmacology Congress, Montreal, Canada. Canadian Journal of Physiology &

Pharmacology 72 (Suppl. 2): P1. 14, pp. 39.

33. Sharma, J. N. (1995). Prospect of Kinin Receptor Antagonist as Novel Antirheumatic

Drug. 6th Intersciences World Conference on Inflammation, Antirheumatics, Analgesics,

Immunomodulators, Geneva, Switzerland. Abstract No. 35.

34. Uma, K., Sharma, J. N. and Noor, A. R. (1995). Importance of Kinin System in Preventing

Left Ventricular Hypertrophy in Diabetic and Hypertensive Rats. 6th Intersciences World

Conference on Inflammation, Antirheumatics, Analgesics, Immunomodulators, Geneva,

Switzerland. Abstract No. 33.

35. Kadir, Z., Sharma, J. N., Uma, K. and Sulaiman, S. A. (1995). Changes in Kallikrein- Kinin

System in Experimental Epilepsy in Rats. 6th Intersciences World Conference on

Inflammation, Antirheumatics, Analgesics, Immunomodulators, Geneva, Switzerland.

Abstract No. 34.

36. Sharma, J. N. and Uma, K. (1995). Effect of Captopril on Kallikrein- Kinin System in

Hypertensive and Normotensive Rats with and without Diabetes. 14th International

Symposium on Kinins, Denver, September 1995. Abstract No. C51.

35


37. Uma, K. and Sharma, J. N. (1995). Changes in Cardiac and Renal Kallikrein- Kinin System

in Hypertensive and Normotensive Rats with and without Diabetes. 14th International


38. Akbar, A., Sharma, J. N. and Gan, E. K. (1995). Effect of Indomethacin on Bradykinin-

Induced Responses in the Guinea- Pig Tracheal Smooth Muscle. 14th International


39. Sharma, J. N., Yusof, A. P. M. and Ishak, F. I. (1996). Significance of the Kinin System in

Pathophysiology of Inflammatory Joint Disease. 16th Asian Congress of Pharmaceutical

Sciences, Kuala Lumpur, Malaysia, November 1996. Abstract No. A- 14.

40. Sharma, J. N., Yusof, A. P. M. and Ishak, F. I. and Srivastava, K. C. (1997). Suppressive

Effects of Eugenol and Ginger Oil on Arthritic Rats: Possible Role of Kallkrein. 7 th

Intersciences World Conference on Inflammation, Antirheumatics, Analgesics,

Immunodulators, Geneva, Switzerland, May 1997. International Journal of Tissue

Reactions 19: 54.

41. Sharma, J. N., Uma, K. and Yusof, A. P. M. (1998). Altered Tissue and Plasma Kininogen

Levels in Hypertensive and Diabetic Rats. 15th International Conference on Kinins, Nara,

Japan, October 1998. Abstract No. O- V- 3 (pp. 71).

42. Abbas, S. A., Sharma, J. N. and Yusof, A. P. M. (1998). The Effect of Bradykinin and Its

Antagonist on Survival Time After Coronary Artery Occlusion in Hypertensive and

Normotensive Rats. 15th International Conference on Kinins, Nara, Japan, October 1998.

Abstract No. P- 14 (pp. 83).

43. Samud, A. M., Asmawi, M. Z. and Sharma, J. N. (1998). Anti- inflammatory Activity of

Crinum Asiaticum Plant and Its Effect on Bradykinin Induced Contractions on Isolated

Uterus. 15th International Conference on Kinins, Nara, Japan, October 1998. Abstract No.

P- X- 18 (pp. 145).

44. Abbas, S. A., Sharma, J. N., Yusof, A. P. M. and Shah, R. P. (1999). The Effect of Tissue

Kallikrein and Captopril on Survival Time After Coronary Artery Ligation in

36


Spontaneously Hypertensive Rats. 14th Meeting of the Malaysian Society of

Pharmacology and Physiology, Penang, Malaysia, May 1999. Abstract No. OR6.

45. Asmawi, M. Z., Samud, A. M., Sharma, J. N., Yusof, A. P. M. (1999). Anti- inflammatory

Activity of the Fractional Extract of Plant Crinum Asiaticum, 14th Meeting of the

Malaysian Society of Pharmacology and Physiology, Penang, Malaysia, May 1999.

Abstract No. OR 11.

46. Abbas, A. S., Sharma, J. N., Yusof, A. P. M., Das P. K. and Shah, R. P. (1999). The Effect of

Bradykinin on Cardiac Morphology on Normotensive and Hypertensive Rats. 14th

Meeting of the Malaysian Pharmacology and Physiology, Penang, Malaysia, May 1999.

Abstract No. P1.

47. Sharma, J. N. (2000). Kinin System in Protecting the Heart. National Symposium on

Health Sciences, Kuala Lumpur, Malaysia, April 2000. Abstract No 80.

48. Sharma, J. N., Abbas, S. A., Yusof, A. P. M. and Shah, R. P. (2002). Evaluation of tissue

kallikrein and captopril activities on survival time after coronary artery ligation in

hypertensive rats. Kinin 2002: The 16th International Conference, Charleston, SC, USA,

May 26- 31, 2002. Abstract No. O-68.

49. Sharma, J. N. (2003). Recent advances in the kallikrein-kinin system in inflammatory

disorders. International Conference on Inflammopharmacology 2003, Royal College of

Physicians of Edinburgh, UK, April 22-24, 2003. Inflammopharmacology Abstract No. 36

(pp.56-57).

50. Sharma, J. N. (2003). Significance of the kinin system in the cardiovascular disorders.

7th International symposium on Pharmaceutical Sciences, Ankara University Faculty of

Pharmacy, Ankara, Turkey, June 24-27, 2003. Proceeding Abstract No. PL-29 (pp.96-98).

51. Sharma, J. N. (2004). The kallikrein-kinin system in cardiovascular disorders- a new

therapeutic modality found? The Philippines Society of Experimental and Clinical

Pharmacology Meeting, Manila, Philippines, May 7, 2004.

37


52. Sharma, J. N. (2004). Bradykinin agonists in the treatment of cardiovascular disorders. The

20th Federation of Asian Pharmaceutical Association Congress, Bangkok, Thailand,

November 30 –December 3, 2004. Proceeding Abstract pp. 207.

53. Sharma, J. N. (2005). The role of nutraceuticals in therapeutics: myth or reality.

The 20th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology,

Penang, Malaysia, April 25-27, 2005, Proceeding Abstract pp 1.

54. Sharma, J. N., Kadir, Z and Uma, K . (2007). Evaluation of the kinin-forming components in

experimental epilepsy in rats. KININ 2007, 2nd International Conference on Exporing the

Future of Vascular and Inflammatory mediators, Berlin, Germany, May 30-June 2, 2007.

Proceeding Abstract P61, pp.119.

55. Sharma, J. N. and Abbas, S. A. (2008). Effect of bradykinin antagonist on beneficial effect of

captopril on duration of survival after acute coronary artery ligation in hypertensive rats.

The IXth World conference on Clinical Pharmacology and Therapeutics, Quebec, Canada,

July 27-August 1, 2008. Proceeding abstract No. T2TH041.

56. Sharma, J. N. and Uma, K. (2009). Effect of captopril on cardiac wall thickness, blood

pressure and kinin-components in diabetic Wistar-Kyoto (WKY) rats. The 2nd Kuwait

International Pharmaceutical Conference (KIPC), Kuwait, March 1 to March 3, 2009.

Proceeding abstract No. 35. Poster.

57. Sharma, J. N. (2009). Role of bradykinin system in hypertension: prospects for future drug

therapy. 4th Asian Association of Schools of Pharmacy and 9 th Malaysian Pharmaceutical

Society Conference, Penang, Malaysia. June 10 to June 13, 2009. Abstract No. page

58. Sharma, J. N. (2010) : Bradykinin system and rheumatoid arthritis: An overview.

24th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology, Shah

Alam, Kuala Lumpur, Malaysia, June 2-3, 2010. Abstract Page No. 35.

38


59. Sharma, J. N. (2011). Effect of indomethacin and prednisolone on tissue kallikrein activity in

arthritic rats. The 3rd Kuwait International Pharmaceutical Conference (KIPC 2011), Kuwait,

14-16 February 2011. Proceeding abstract No. 63, page 97. Poster.

60. Sharma, J. N. (2011). Kallikrein-kinin pathway in cardiovascular and renal system:

possibility for new drug development. 25th Scientific Meeting of the Malaysian Society of

Pharmacology and Physiology, Serdang, Selangore, Malaysia, May 25- 26, 2011. Abstract

Page No. 14. Plenary Lecture 4.

61. Sharma, J. N. (2012). Bradykinin system: Role in hypertension and diabetes. 26 th Scientific

Meeting of the Malaysian Society of Pharmacology and Physiology, Penang, Malaysia, May

18-20, 2012. Abstract Page No. 39. Plenary Lecture 6.

62. Sharma, J. N. (2013). : Kallikrein-kinin pathways in cardio-renal system: prospect of new

drug development. 27th Scientific Meeting of the Malaysian Society of Pharmacology and

Physiology, Kuantan, Malaysia, September 6 - 8, 2013. Abstract -40. Plenary Lecture

3.

63. Sharma, J. N.; Al-Shoumer, K. A. S., Matar, K. M. and Madathil, N. V. (2013). Abnormal

regulation of bradykinin-foring components in Kuwaiti patients with type 2 diabetes. The 5 th

International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia

and Diabetes Mellitus, Bangkok, Thailand, November 21-24, 2013. Oral presentation.

64. Sharma, J. N.; Al-Shoumer, K. A. S., Matar, K. M. and Madathil, N. V. (2014).

Abnormal pattern of bradykinin forming components and nitric oxide in Kuwaiti

patients with type 2 diabetes, 19th HSC Poster Conference, Kuwait University,

Kuwait. May 21-24, 2014. Poster presentation no. 184.

39


65. Sharma, J. N. , Al-Shoumer, K. A. S., Matar, Madathil, N. V. and Al-Moalem,

A.M.K. ( 2015). 'Influence of oral hypoglycemic agent on kininase II and nitric

oxide activities in Kuwaiti patients with type 2 diabetes,' 20th HSC Poster

Conference, Kuwait University, Kuwait. May 5-7 , 2014. Poster presentation no.

180.

ADVISOR AND EVALUATOR OF NATINAL AND INTERNATIONAL RESEARCH

GRANTS

INTERNATIONAL:

40


1. Telethon Combatti La Distrofia mauculare E Le Altre Malattie Genetiche, Rome, Italy.

July 1999.

2. International Foundation for Science, Stockholm, Sweden. October 2001.

3. Raine Priming Grants, School of Medicine and Pharmacology, The University of Western

Australia, Perth, WA. May 2010.

NATIONAL:

1. Kuwait Foundation for the Advancement of Science, Kuwait. April, 2003.

2. Member of the Kuwait University Scientific Consultant Council, June, 2003.

3. Kuwait University Research Project, Kuwait, April, 2004.

4. Kuwait University Research Project, Kuwait, May, 2006.

5. Kuwait University Research Project, Kuwait, February, 2008.

41


42

cv of jn sharma

Documents